Danyelza 40mg/10 mL (4 mg/mL) injection Images
Generic Name: naxitamab
This medication has been identified as Danyelza 40mg/10 mL (4 mg/mL) injection. It is supplied by Y-mAbs Therapeutics, Inc.
Danyelza is used in the treatment of Neuroblastoma and belongs to the drug class miscellaneous antineoplastics. Danyelza 40mg/10 mL (4 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Danyelza
- Generic Name
- naxitamab
- Strength
- 40mg/10 mL (4 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Y-mAbs Therapeutics, Inc.
- National Drug Code (NDC)
- 73042-0201
See also:
More about Danyelza (naxitamab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.